Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover bid for the group is in trouble. The Financial Times has said that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback